Endocrinologists, nutritionists, and personal trainers explain why it's important to stick to your workout routine when ...

DOCTORS have dubbed her the “Ozempic poster girl” after she managed to keep her six stone weight loss off for two YEARS after ...

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

USA: A study published in Obesity Pillars has revealed that individuals taking GLP-1 receptor agonists (GLP-1RAs) experienced ...

Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...

In patients with type 2 diabetes (T2D), the risk of major adverse cardiovascular events (MACEs) was lowest among patients ...

This article was reviewed by Lynn Marie Morski, MD, JD. Ozempic Stomach Paralysis: Risks & Treatments Key takeaways: Stomach ...

More work needs to be done to tease out the mechanisms by which GLP-1 RAs lower the risk of MACE, researchers say.

Analysts have set 12-month price targets for West Pharmaceutical Servs, revealing an average target of $336.2, a high ...

"UK regulators seize illegal weight loss drugs amid global pricing shake-up" was originally created and published by ...